EGRP-Supported Epidemiology Consortia
| Title of Initiative | NIH Contacts | Lead Contacts/Principal Investigators | EGRP-Funded Grant (if appropriate) | Consortia Type | Year EGRP Facilitation and/or Funding Began |
|---|---|---|---|---|---|
Pacific Ovarian Cancer Research Consortium (POCRC) |
EGRP/NCI: Daniela Seminara, Ph.D., M.P.H. seminard@mail.nih.gov |
Includes various EGRP-funded investigators teamed with DCEG investigators.
One contact: |
Case-control | ||
Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA 1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers) |
EGRP/NCI: Daniela Seminara, Ph.D., M.P.H., seminard@mail.nih.gov |
Lead Contact/PI: Timothy Rebbeck, Ph.D. University of Pennsylvania trebbeck@cceb.med.upenn.edu |
Modifiers of Cancer Risk in BRCA 1/2 Mutation Carriers R01CA102776 | Cohort study, Nested case-control, Cases only | 2004 |
| Prophylactic Surgery in Carriers of BRCA 1/2 Mutations R01CA083855 | Cohort study, Nested case-control, Cases only | 2000 | |||
| Susan Neuhausen, Ph.D. University of California at Irvine sneuhaus@uci.edu |
Genetic Epidemiology of Breast Cancer – BRCA1 and BRCA R01CA074415 | Cohort study, Nested case-control, Cases only | 1998 |
| Key to Acronyms Used in Tables | |
|---|---|
| EGRP | Epidemiology and Genetics Research Program |
| CDC | Centers for Disease Control and Prevention |
| DCB | Division of Cancer Biology |
| DCEG | Division of Cancer Epidemiology and Genetics |
| NCI | National Cancer Institute |
| NHGRI | National Human Genome Research Institute |
| NIEHS | National Institute of Environmental Health Sciences |
| NIH | National Institutes of Health |
| OCS | Office of Cancer Survivorship |
| OD | Office of the Director |
